Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study in WT1-Expressing Non-small Cell Lung Cancer and Mesothelioma, Comparing Cellular Adoptive Immunotherapy With Polyclonal Autologous Central Memory to Naïve CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T-Cell Receptor

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02408016
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:30.608053+00:00
Published At
2021-09-13T00:00:00+00:00
Record Updated At
2021-09-13
Results Posted At
2021-09-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Pleural Malignant Mesothelioma", "HLA-A*0201 Positive Cells Present", "Recurrent Non-Small Cell Lung Carcinoma", "Recurrent Pleural Malignant Mesothelioma", "Stage III Non-Small Cell Lung Cancer AJCC v7", "Stage III Pleural Malignant Mesothelioma AJCC v7", "Stage IIIA Non-Small Cell Lung Cancer AJCC v7", "Stage IIIB Non-Small Cell Lung Cancer AJCC v7", "Stage IV Non-Small Cell Lung Cancer AJCC v7", "Stage IV Pleural Malignant Mesothelioma AJCC v7", "WT1 Positive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-09-13"
protocolSection.identificationModule.nctId
"NCT02408016"
protocolSection.identificationModule.officialTitle
"Phase I/II Study in WT1-Expressing Non-small Cell Lung Cancer and Mesothelioma, Comparing Cellular Adoptive Immunotherapy With Polyclonal Autologous Central Memory to Na\u00efve CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T-Cell Receptor"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-09-13"

Study condition terms

  • Advanced Pleural Malignant Mesothelioma (protocolSection.conditionsModule.conditions)
  • HLA-A*0201 Positive Cells Present (protocolSection.conditionsModule.conditions)
  • Recurrent Non-Small Cell Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Pleural Malignant Mesothelioma (protocolSection.conditionsModule.conditions)
  • Stage III Non-Small Cell Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Pleural Malignant Mesothelioma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Non-Small Cell Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Non-Small Cell Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Pleural Malignant Mesothelioma AJCC v7 (protocolSection.conditionsModule.conditions)
  • WT1 Positive (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.